(Q34616881)

English

Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit